These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8922345)

  • 21. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
    Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K
    Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
    Soualmia H; Ayadi I; Omar S; Feki M; Drissa H; Mebazaa A; Kaabachi N
    Clin Lab; 2009; 55(3-4):120-7. PubMed ID: 19462934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.
    Holmgren D; Westerlind A; Lundberg PA; Wåhlander H
    Clin Physiol Funct Imaging; 2005 Sep; 25(5):263-9. PubMed ID: 16117728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C; Metzele A; Kochs M; Hombach V; Grünert A
    Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms.
    Pemberton CJ; Yandle TG; Charles CJ; Rademaker MT; Aitken GD; Espiner EA
    J Endocrinol; 1997 Dec; 155(3):541-50. PubMed ID: 9487999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
    Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
    JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
    Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
    Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
    Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
    Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients.
    Corboy JC; Walker RJ; Simmonds MB; Wilkins GT; Richards AM; Espiner EA
    Clin Sci (Lond); 1994 Dec; 87(6):679-84. PubMed ID: 7874859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
    Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy.
    Ogino K; Ogura K; Kinugawa T; Osaki S; Kato M; Furuse Y; Kinugasa Y; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Circ J; 2004 May; 68(5):444-50. PubMed ID: 15118286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis.
    Hori Y; Tsubaki M; Katou A; Ono Y; Yonezawa T; Li X; Higuchi SI
    J Vet Intern Med; 2008; 22(5):1118-23. PubMed ID: 18681918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.